VENETOCLAX
venetoclax 10 mg tablet [14] (&) venetoclax 50 mg tablet [7] (&) venetoclax 100 mg
tablet [7] (&) venetoclax 100 mg tablet [14], 1 pack
VENETOCLAX (12188L)
12188L
Manner of administration:Oral
Restriction
Indication: Chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)
Treatment phase: Initial treatment in first-line therapy - Dose titration (weeks 1 to 4 of a 5-week
ramp-up schedule)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $1,706.83 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Venclexta | |||||
